Subjective and Objective Clinical Manifestations
Subjectively, Mr. C. is a 32-year-old male seeking the information at the outpatient center regarding possible bariatric surgery for his obesity. His health history indicates that he has been overweight since childhood and has gained approximately 100 pounds in the last 2-3 years. He has also been diagnosed with sleep apnea and hypertension, which he attempts to control by restricting dietary sodium. Additionally, he has reported increasing shortness of breath with activity, swollen ankles, and pruritus over the last six months (Diaz et al., 2020). Objectively Mr. C.’s physical examination reveals a height of 68 inches and a weight of 134.5 kg. His blood pressure was 172/98, his heart rate was 88, and his respiratory rate was 26. Additionally, there was 3+ pitting edema present bilaterally on his feet and ankles. His fasting blood glucose was 146 mg/dL, his total cholesterol was 250 mg/dL, his triglycerides were 312 mg/dL, his HDL was 30 mg/dL, his serum creatinine was 1.8 mg/dL, and his BUN was 32 mg/dL (Gürkov et al., 2019).
Potential health risks for obesity
Obesity is a significant public health concern associated with many physical and psychological health risks. It is a condition of excess body fat defined by an individual having a Body Mass Index (BMI) of 30 or higher. Although BMI does not account for muscle mass, it is still an effective tool for assessing obesity levels. The potential health risks associated with obesity are numerous and far-reaching. Physically, obesity can lead to an increased risk of developing type 2 diabetes, hypertension, high cholesterol, and heart disease (Chooi et al., 2019). Additionally, obesity can lead to an increased risk of developing several types of cancer, including colorectal, endometrial, gallbladder, and breast cancer. Furthermore, obesity can cause a decrease in physical functioning, leading to issues with mobility (Loos & Yeo, 2022)
Psychologically, obesity can have a negative impact on one’s self-esteem and body image. This can lead to issues of depression and anxiety, as well as social isolation. Furthermore, self-esteem issues can lead to emotional eating, which can cause further weight gain and the continuation of the vicious cycle of obesity. Given Mr. C.’s health history and physical examination, he is at an increased risk for many physical and psychological health risks associated with obesity. His weight of 134.5 kg, combined with his height of 68 inches, puts him in the obese BMI range, thus increasing his risk for the aforementioned physical and psychological health risks.
Bariatric surgery may be an appropriate intervention for Mr. C, given the significant health risks associated with his obeBariatric surgery misery is to produce significant and sustained weight loss and improve the associated medical conditions. However, bariatric surgery is an effective procedure with potential risks and long-term effects. It should only be considered after a thorough evaluation by a multidisciplinary team, including a dietitian, psychologist, and physician (Arterburn et al., 2020). It is also essential for Mr. C. to understand that bariatric surgery is not a cure for obesity and requires significant lifestyle changes, including dietary changes, physical activity, and follow-up medical care, for optimal outcomes.
Potential or Actual Problems Faced by Mr C
Despite trying to limit his sodium intake, Mr. C. has not been able to achieve or maintain his ideal weight and has expressed frustration with his health. This suggests that his perception of his health could be more accurate and that he needs a complete understanding of the processes underlying his diseases. Low levels of confidence and treatment plan adherence can result from this. Management of Health Conditions: Mr. C. has not been able to successfully treat his hypertension, sleep apnea or maintain his ideal body weight. This suggests that he may benefit from enhancing his health management abilities in order to handle his chronic conditions better (Veasey & Rosen, 2019)
Mr. C. may need to eat the healthiest diet possible due to his high body mass index and fasting blood glucose level of 146 mg/dL. He has also been trying to manage his hypertension, but more than his dietary sodium restrictions may be needed. As for Mr. C.’s metabolism, his high total cholesterol of 250 mg/dL and triglycerides of 312 mg/dL suggest he has a metabolic disorder like diabetes or dyslipidemia. His kidney function needs to be closely monitored because his serum creatinine is 1.8 mg/dL, and his BUN is 32 mg/dL. Mr. C.’s obesity may contribute to his complaint of becoming increasingly out of breath during physical exertion. This suggests he may need the recommended amount of exercise, which can lead to additional weight gain and diminished physical ability. His swollen ankles may indicate that he has been inactive or is holding too much fluid.
Stages of renal disease that leads to end-stage renal disease (ESRD)
Renal disease is a progressive condition that, if left untreated, can progress to end-stage renal disease (ESRD). An irreversible loss of kidney function is known as an end-stage renal disease (ESRD), which occurs when the kidneys can no longer filter and eliminate waste products from the body in an acceptable manner (Smith et al., 2019). In most cases, this results from a gradual decline in kidney function over time. There are several stages of renal disease, the most severe of which is end-stage renal disease. These stages include mild renal insufficiency, moderate renal insufficiency, severe renal insufficiency, and end-stage renal disease. The presence of obesity, hypertension, high cholesterol, diabetes, and a history of renal illness in Mr. C.’s family are all risk factors that could contribute to end-stage renal disease (ESRD). These disorders, if left untreated, can cause further damage to the kidneys, which may eventually result in end-stage renal disease (ESRD). In addition, the increased serum creatinine and BUN levels that Mr. C. has shown that his kidney function is not at its best and that he may be in the beginning stages of renal failure (Niewczas et al., 2019). Therefore, Mr. C. needs to keep a careful eye on his condition and adhere to an effective treatment plan to reduce the likelihood of his condition deteriorating further and leading to end-stage renal disease (ESRD).
Prevention of End-Stage Renal Disease (ESRD) and Health Promotion Opportunities for Mr. C
Mr. C. needs to understand the risk factors associated with ESRD and what he can do to reduce his chances of developing the condition. Patient education should include maintaining a healthy diet, regular physical activity, controlling hypertension, and managing diabetes. He should also be advised to limit his sodium intake and reduce his total cholesterol and triglyceride levels through dietary and lifestyle changes (Niewczas et al., 2019).
In order to promote health restoration, Mr. C. should be provided with information on lifestyle modifications that can help to reduce his risk of developing ESRD. These modifications include quitting smoking, managing stress, maintaining a healthy weight, and reducing alcohol consumption. He should also be educated on the importance of regular physical activity, including resistance training, which can help to improve his overall health.
Finally, Mr. C. should be provided with information on the importance of avoiding further deterioration of his renal status. This includes avoiding certain medications, such as NSAIDs and certain antibiotics, which can harm the kidneys. He should also be informed of the importance of avoiding dehydration and staying hydrated. Additionally, he should be educated on the importance of avoiding exposure to certain toxins, such as lead and mercury, and avoiding activities that could cause further damage to the kidneys, such as strenuous physical activity and recreational drug use.
Resources available for ESRD patients for non-acute care
For non-acute care, ESRD patients have access to various resources to help them manage their condition. These resources include devices, transportation, living conditions, and return-to-employment issues. Devices such as dialysis machines, infusion pumps, and other medical equipment can help manage ESRD (Marienne et al., 2021). In addition, transportation services can be arranged to help patients with transportation to and from medical appointments. For those with financial difficulties, there are also financial assistance programs available.
Living conditions for ESRD patients can be improved through home modifications. This may include making sure the home is wheelchair accessible, installing ramps, widening doorways, and making other changes to make it easier for the patient to move around (Rysz et al., 2020). A multidisciplinary approach is essential for ESRD patients to ensure they receive the best care possible. This includes a team of specialists, such as nephrologists, dietitians, social workers, and psychologists, who can work together to provide comprehensive care. This team can help address the patient’s physical, psychological, and social needs, as well as provide education and support. Additionally, the team can help coordinate care and ensure that the patient receives the most appropriate treatment for their condition.
Arterburn, D. E., Telem, D. A., Kushner, R. F., & Courcoulas, A. P. (2020). Benefits and risks of bariatric surgery in adults: a review. Jama, 324(9), 879-887.
Chooi, Y. C., Ding, C., & Magkos, F. (2019). The epidemiology of obesity. Metabolism, 92, 6-10.
Diaz, J. H., Warren, R. J., & Oster, M. J. (2020). The disease ecology, epidemiology, clinical manifestations, and management of trichinellosis linked to consumption of wild animal meat. Wilderness & environmental medicine, 31(2), 235-244.
Gürkov, R., Jerin, C., Flatz, W., & Maxwell, R. (2019). Clinical manifestations of hydropic ear disease (Menière’s). European Archives of Oto-Rhino-Laryngology, pp. 276, 27–40.
Loos, R. J., & Yeo, G. S. (2022). The genetics of obesity: from discovery to biology. Nature Reviews Genetics, 23(2), 120–133.
Marienne, J., Laville, S. M., Caillard, P., Batteux, B., Gras-Champel, V., Masmoudi, K., … & Liabeuf, S. (2021). Evaluation of changes over time in the drug burden and medication regimen complexity in ESRD patients before and after renal transplantation. Kidney International Reports, 6(1), 128-137.
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., … & Krolewski, A. S. (2019). A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes. Nature medicine, 25(5), 805-813.
Rysz, J., Franczyk, B., Ławiński, J., & Gluba-Brzózka, A. (2020). Oxidative stress in ESRD patients on dialysis and the risk of cardiovascular diseases. Antioxidants, 9(11), 1079.
Smith, R. J., Appel, G. B., Blom, A. M., Cook, H. T., D’Agati, V. D., Fakhouri, F., … & Nester, C. M. (2019). C3 glomerulopathy—understanding a rare complement-driven renal disease. Nature reviews nephrology, 15(3), 129-143.
Veasey, S. C., & Rosen, I. M. (2019). Obstructive sleep apnea in adults. New England Journal of Medicine, 380(15), 1442–1449.